LifeMD, Inc. (LFMDP) Cost of Revenue (2012 - 2025)

LifeMD (LFMDP) has 14 years of Cost of Revenue data on file, last reported at $4.2 million in Q4 2025.

• Quarterly Cost of Revenue fell 37.78% year-over-year to $4.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $27.7 million (up 29.26% YoY) and the FY2025 annual result came in at $27.7 million, up 29.26% from the prior year.
• Cost of Revenue declined to $4.2 million in Q4 2025, from $7.4 million in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $8.6 million in Q1 2025 to a low of $3.2 million in Q1 2021.
• A 5-year average of $5.2 million and a median of $4.9 million in 2023 frame the typical range for Cost of Revenue.
• Annual changes were most pronounced in 2021 — Cost of Revenue surged 204.16% — and 2025, when it sank 37.78%.
• Tracing LFMDP's Cost of Revenue over 5 years: stood at $5.6 million in 2021, then dropped by 26.94% to $4.1 million in 2022, then soared by 31.66% to $5.4 million in 2023, then increased by 27.01% to $6.8 million in 2024, then slumped by 37.78% to $4.2 million in 2025.
• The last three Cost of Revenue figures came in at $4.2 million (Q4 2025), $7.4 million (Q3 2025), and $7.4 million (Q2 2025), per Business Quant data.